Free Atlas analysis example
This public worked example shows how we connect a potential constraint to company evidence, interpretation and questions to monitor. The verified Atlas adds filterable company records, theme-specific research scores and risks.
Full worked example · No sign-up
RKLB · NASDAQ
Updated with the 30 September 2026 Synspective agreement and 26 September mission.
Illustrative analysis reviewed 1 October 2026.
01 / The potential bottleneck
Satellite demand needs launch slots, flight-ready hardware and spacecraft production. The research question is whether Rocket Lab can scale execution alongside orders. Backlog alone does not prove a supply shortage.
02 / The evidence
Q2 revenue was $234 million and backlog reached $2.36 billion. On 30 September Rocket Lab added 20 Electron missions for Synspective, taking its stated launch backlog above 100 missions; on 26 September it completed Electron flight 97, its 18th launch of 2026.
Read the 20-launch agreement →Read the 97th mission update →03 / Our interpretation
A stronger case would combine rising deliveries with improving economics. Track launch cadence, spacecraft revenue and cash use together.
04 / Catalysts to watch
Watch Electron launch cadence and Synspective schedule execution alongside Neutron testing and pad readiness. Contract terms for the new 20-launch agreement were not disclosed, so backlog should not be treated as recognized revenue.
05 / What would weaken the thesis?
Repeated schedule misses, cancellations or worsening cash consumption would weaken the delivery-capacity thesis, even if headline backlog grows.
06 / Investment boundary
This example does not assess today's share price or expected return. Valuation, financing and dilution need a separate review before an investment decision.
The same framework guides our Atlas: constraint, company, evidence, catalyst and conditions that would change our view.